EKF Diagnostics Holdings plc (AIM:EKF)
London
· Delayed Price · Currency is GBP · Price in GBX 25.00
-0.50 (-1.96%)
Apr 28, 2026, 4:35 PM GMT
EKF Diagnostics Holdings Revenue
In the year 2025, EKF Diagnostics Holdings had annual revenue of 51.56M GBP with 2.73% growth. EKF Diagnostics Holdings had revenue of 26.33M in the half year ending December 31, 2025, with 2.28% growth.
Revenue
51.56M
Revenue Growth
+2.73%
P/S Ratio
2.09
Revenue / Employee
173.62K
Employees
297
Market Cap
107.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 51.56M | 1.37M | 2.73% |
| Dec 31, 2024 | 50.19M | -2.42M | -4.59% |
| Dec 31, 2023 | 52.61M | -14.02M | -21.05% |
| Dec 31, 2022 | 66.64M | -15.20M | -18.57% |
| Dec 31, 2021 | 81.84M | 16.58M | 25.40% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Diaceutics | 34.40M |
| Scancell Holdings | 4.71M |
| Shield Therapeutics | 36.93M |
| Bioventix | 12.54M |
EKF Diagnostics Holdings News
- 5 weeks ago - EKF Diagnostics Holdings Earnings Call Transcript: H2 2025 - Transcripts
- 8 months ago - EKF Diagnostics Holdings Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - EKF Diagnostics Holdings Earnings Call Transcript: H2 2024 - Transcripts